BOSTON SCIENTIFIC CORPORATION
Scientific Corporation is a worldwide developer, manufacturer and
marketer of medical devices with more than 15,000 employees and
revenue of $3.5 billion in 2003. For 25 years, Boston Scientific
has advanced the practice of less-invasive medicine by providing
a broad and deep portfolio of innovative products, technologies
and services across a wide range of medical specialties.
of their recent innovations include the TAXUS™ Express2™
paclitaxel-eluting coronary stent system, a revolutionary new treatment
for coronary artery disease; the Enteryx® technology, an endoscopic,
injectable new treatment for the symptoms of gastroesophogeal reflux
disease (GERD); Matrix™ Detachable Coils, a next-generation
aneurysm therapy designed to prevent aneurysms from rupturing and
to promote healing; the Contour SE™ embolic agent for treating
uterine fibroids through uterine fibroid embolization (a less-invasive
alternative to surgery); and the Hydro ThermAblator® Endometrial
Ablation System for the treatment of excessive menstrual bleeding
due to benign causes.
Through organic research and development,
investments and acquisitions, Boston Scientific continues to develop
a broad range of new products and technologies to help physicians
improve patients’ lives.